nektar therapeutics (NKTR:NASDAQ GS)
Robert B. Chess
Chairman, Nektar Therapeutics
|Age||Total Calculated Compensation||This person is connected to 140 board members in 6 different organizations across 6 different industries.|
See Board Relationships
Mr. Robert B. Chess, also known as Rob, served as Chief Executive Officer of OPX Biotechnologies, Inc. Mr. Chess served as the President and Chief Executive Officer of Nektar Therapeutics from March 17, 2006 to January 15, 2007 and served as its Interim President and Acting Chief Executive Officer from March 17, 2006 to January 15, 2007. Mr. Chess served as an Interim President and Chief Executive Officer of Nektar Therapeutics, from 1992 to 2000. He served as Co-Chief ...
455 Mission Bay Boulevard SouthPhone: 415-482-5300
San Francisco, California 94158
Board Members Memberships*
Independent Director and Member of Nominating & Corporate Governance Committee
Harvard Business School
California Institute of Technology
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Michael W. Aguiar||Chief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer, Senior Vice President of Finance, Treasurer and Director|
|Peter M. Hecht Ph.D.||Co-Founder, Chief Executive Officer and Director|
Ironwood Pharmaceuticals, Inc.
|James A. Schoeneck||Chief Executive Officer, President and Director|
|George Frederick Wilkinson||Chief Executive Officer, President and Director|
Impax Laboratories Inc.
|Peter S. Greenleaf||Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee|
Sucampo Pharmaceuticals, Inc.
|--||Compensation as of Fiscal Year 2013.|